MedicationsMyBlueDotsStudy finds no elevated risk of thyroid cancer among GLP1-RA users MyBlueDots5 months ago01 mins A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer. Go to Sourcehttps://medicalxpress.com/rss-feed/ Post navigation Previous: Survey shows previous experience affects family planning decisions of people with hereditary dementiaNext: Framework outlines steps for achieving health equity in stroke care
‘Master control switch’ protein that heightens neurodegenerative disease offers new treatment target MyBlueDots3 days ago 0
New findings reveal how the heart is organized from the earliest stages of embryonic development MyBlueDots3 days ago 0
Scholastic performance is a key concern for young cancer patients, study finds MyBlueDots3 days ago 0